1.An Engineering View on Megatrends in Radiology: Digitization to Quantitative Tools of Medicine.
Namkug KIM ; Jaesoon CHOI ; Jaeyoun YI ; Seungwook CHOI ; Seyoun PARK ; Yongjun CHANG ; Joon Beom SEO
Korean Journal of Radiology 2013;14(2):139-153
Within six months of the discovery of X-ray in 1895, the technology was used to scan the interior of the human body, paving the way for many innovations in the field of medicine, including an ultrasound device in 1950, a CT scanner in 1972, and MRI in 1980. More recent decades have witnessed developments such as digital imaging using a picture archiving and communication system, computer-aided detection/diagnosis, organ-specific workstations, and molecular, functional, and quantitative imaging. One of the latest technical breakthrough in the field of radiology has been imaging genomics and robotic interventions for biopsy and theragnosis. This review provides an engineering perspective on these developments and several other megatrends in radiology.
Biological Markers/analysis
;
Biomedical Engineering
;
Diagnosis, Computer-Assisted/*trends
;
Diagnostic Imaging/*trends
;
Equipment Design
;
Genomics
;
Humans
;
Image Processing, Computer-Assisted/*trends
;
Radiology Information Systems/*trends
;
Robotics
;
Systems Integration
;
User-Computer Interface
2.Long-term disease-free survival of patients with primary cardiac lymphoma treated with systemic chemotherapy and radiotherapy.
Dong Yeop SHIN ; Yun Gyoo LEE ; Hyun Jung LEE ; Seyoun CHOI ; Jin Joo PARK ; Dong Wan KIM
Korean Journal of Hematology 2010;45(4):282-285
Primary cardiac lymphoma (PCL) is a rare disease entity with only a few reported cases in Korea. In this paper, we report a case of PCL in a 59-year-old man presenting with chest pain. Diffuse large B-cell lymphoma was diagnosed through a cardiac catheterization-assisted percutaneous endomyocardial biopsy, and there was no evidence of extracardiac involvement of the lymphoma.The patient had a complete clinical response after systemic chemotherapy with a rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) regimen and additional post-chemotherapeutic radiation therapy. The patient experienced a long-term disease-free survival of over 4 years. However, he received coronary artery bypass graft surgery due to an acute myocardial infarction that occurred 3 years after the completion of the radiation therapy. Although the addition of radiation therapy to the treatment is thought to decrease the risk of relapse in patients with PCL, a careful and thorough consideration of the potential complications of radiation therapy, particularly with respect to cardiac complications, should be considered.
Antibodies, Monoclonal, Murine-Derived
;
Biopsy
;
Chest Pain
;
Coronary Artery Bypass
;
Cyclophosphamide
;
Disease-Free Survival
;
Doxorubicin
;
Humans
;
Korea
;
Lymphoma
;
Lymphoma, B-Cell
;
Middle Aged
;
Myocardial Infarction
;
Prednisolone
;
Rare Diseases
;
Recurrence
;
Transplants
;
Vincristine
;
Rituximab